Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1676
    +0.0019 (+0.17%)
     

  • GBP/USD

    1.2492
    -0.0019 (-0.15%)
     

  • Bitcoin GBP

    51,118.43
    -582.66 (-1.13%)
     

  • CMC Crypto 200

    1,331.56
    -64.98 (-4.49%)
     

  • S&P 500

    5,105.99
    +57.57 (+1.14%)
     

  • DOW

    38,270.26
    +184.46 (+0.48%)
     

  • CRUDE OIL

    83.62
    +0.05 (+0.06%)
     

  • GOLD FUTURES

    2,349.20
    +6.70 (+0.29%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Why Vir Biotechnology Is Up More Than 13% Today

James Brumley, The Motley Fool
·1-min read
Why Vir Biotechnology Is Up More Than 13% Today

Shares of biopharma company Vir Biotechnology (NASDAQ: VIR) are up 13.7% as of 11:57 a.m. ET on Monday in response to reports that a new strain of the COVID-19 virus has been identified. Indeed, headlines regarding the new omicron variant of the coronavirus began to surface before Thursday's Thanksgiving holiday. It just took a while for investors to connect the dots all the way back to Vir Biotechnology, which potentially benefits from a renewed outbreak of infections stemming from this new strain of the pandemic-causing virus.

Continue reading